Transforming the Pace of Innovation at Alnylam

Our latest case study with Alnylam Pharmaceuticals demonstrates how we helped them to discover novel targets and insights using our integrative analytics platform.
REVEAL helps pharmaceutical companies like Alnylam discover novel targets in weeks and move more quickly into clinical trials.

Featured Download

Examination of a methylation-driven breast cancer gene panel using UK Biobank, TCGA, and single cell Human Cell Atlas datasets – presented at the American Society of Human Genetics Conference 2022.